Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Ardelyx Inc (NASDAQ: ARDX) was $5.54 for the day, down -2.29% from the previous closing price of $5.67. In other words, the price has decreased by -$2.29 from its previous closing price. On the day, 3.79 million shares were traded. ARDX stock price reached its highest trading level at $5.68 during the session, while it also had its lowest trading level at $5.52.
Ratios:
Our analysis of ARDX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.03. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on November 11, 2024, Downgraded its rating to Neutral and sets its target price to $5.50 from $11 previously.
On July 02, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $15 to $7.
On April 05, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $14.Leerink Partners initiated its Outperform rating on April 05, 2024, with a $14 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when RAAB MICHAEL sold 25,000 shares for $5.38 per share. The transaction valued at 134,482 led to the insider holds 1,150,385 shares of the business.
MICHAEL G. RAAB bought 25,000 shares of ARDX for $134,480 on Nov 25 ’24. On Nov 20 ’24, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 7,366 shares for $4.79 each. As a result, the insider received 35,316 and left with 308,745 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1312171136 and an Enterprise Value of 1250634624. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.19 while its Price-to-Book (P/B) ratio in mrq is 8.29. Its current Enterprise Value per Revenue stands at 4.966 whereas that against EBITDA is -20.123.
Stock Price History:
Over the past 52 weeks, ARDX has reached a high of $10.13, while it has fallen to a 52-week low of $4.34. The 50-Day Moving Average of the stock is -4.17%, while the 200-Day Moving Average is calculated to be -16.00%.
Shares Statistics:
ARDX traded an average of 3.89M shares per day over the past three months and 4418080 shares per day over the past ten days. A total of 236.89M shares are outstanding, with a floating share count of 227.84M. Insiders hold about 3.82% of the company’s shares, while institutions hold 61.02% stake in the company. Shares short for ARDX as of 1731628800 were 23308546 with a Short Ratio of 5.99, compared to 1728950400 on 22887200. Therefore, it implies a Short% of Shares Outstanding of 23308546 and a Short% of Float of 11.1899994.
